DC
REGN icon

Davenport & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Davenport & Co’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Buy
543
+55
+11% +$37.4K ﹤0.01% 1154
2026
Q1 		$377K Buy
488
+123
+34% +$94.2K ﹤0.01% 1042
2025
Q4 		$282K Buy
+365
New +$248K ﹤0.01% 1109
2025
Q3 		– Sell
-394
Closed -$207K – 1264
2025
Q2 		$207K Sell
394
-33
-8% -$18.4K ﹤0.01% 1171
2025
Q1 		$271K Buy
+427
New +$294K ﹤0.01% 1036
2024
Q4 		– Sell
-430
Closed -$452K – 1201
2024
Q3 		$452K Buy
430
+60
+16% +$66.8K ﹤0.01% 859
2024
Q2 		$389K Sell
370
-82
-18% -$79.5K ﹤0.01% 879
2024
Q1 		$435K Buy
452
+78
+21% +$74.2K ﹤0.01% 847
2023
Q4 		$328K Sell
374
-3
-0.8% -$2.47K ﹤0.01% 883
2023
Q3 		$310K Sell
377
-2,601
-87% -$2.04M ﹤0.01% 865
2023
Q2 		$2.14M Sell
2,978
-939
-24% -$724K 0.02% 374
2023
Q1 		$3.22M Sell
3,917
-1,015
-21% -$766K 0.03% 317
2022
Q4 		$3.56M Sell
4,932
-90
-2% -$66.4K 0.03% 297
2022
Q3 		$3.46M Sell
5,022
-49
-1% -$30.8K 0.03% 286
2022
Q2 		$3M Buy
5,071
+28
+0.6% +$18.2K 0.02% 311
2022
Q1 		$3.52M Buy
5,043
+243
+5% +$154K 0.02% 315
2021
Q4 		$3.03M Buy
4,800
+2,121
+79% +$1.3M 0.02% 337
2021
Q3 		$1.62M Buy
2,679
+2,141
+398% +$1.33M 0.01% 429
2021
Q2 		$300K Buy
+538
New +$273K ﹤0.01% 786

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Davenport & Co's REGN Position: Q2 2026 in Review

Davenport & Co increased its Regeneron Pharmaceuticals (REGN) stake by 11% in Q2 2026, buying an estimated $37.4K and bringing the position to 543 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1154.

Davenport & Co first reported a position in REGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $3.56M in Q4 2022. 240 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Davenport & Co held 543 shares of Regeneron Pharmaceuticals worth $339K as of Q2 2026.
  • Davenport & Co bought 55 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $37.4K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #1154 holding.
  • Davenport & Co first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • Davenport & Co's Regeneron Pharmaceuticals position peaked at $3.56M in Q4 2022.
  • 240 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.